{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:12:44Z","timestamp":1773277964788,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.autrev.2010.05.021","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T08:31:22Z","timestamp":1275726682000},"page":"695-700","source":"Crossref","is-referenced-by-count":67,"title":["Clinical review about TRAb assay's history"],"prefix":"10.1016","volume":"9","author":[{"given":"Klaus","family":"Z\u00f6phel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Roggenbuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2010.05.021_bib1","first-page":"11","article-title":"Abnormal responses in the assay of thyrotropin","volume":"34","author":"Adams","year":"1956","journal-title":"Proc Univ Otago Med Sch"},{"key":"10.1016\/j.autrev.2010.05.021_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/jcem-24-10-1005","article-title":"Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema","volume":"24","author":"Kriss","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/08916939009041051","article-title":"The structure of thyroid autoantigens","volume":"7","author":"Furmaniak","year":"1990","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2010.05.021_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"12","key":"10.1016\/j.autrev.2010.05.021_bib5","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim","volume":"111","author":"Chen","year":"2003","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.autrev.2010.05.021_bib6","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1210\/en.141.9.3514","article-title":"The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design","volume":"141","author":"Zhang","year":"2000","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.autrev.2010.05.021_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/me.16.4.736","article-title":"Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist","volume":"16","author":"Vlaeminck-Guillem","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"17","key":"10.1016\/j.autrev.2010.05.021_bib8","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1046\/j.1432-1033.2003.03718.x","article-title":"Role of cleavage and shedding in human thyrotropin receptor function and trafficking","volume":"270","author":"Quellari","year":"2003","journal-title":"Eur J Biochem"},{"issue":"7","key":"10.1016\/j.autrev.2010.05.021_bib9","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1210\/en.2002-220884","article-title":"Functional assessment of the thyrotropin receptor-beta subunit","volume":"144","author":"Ciullo","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2010.05.021_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2009.03.012","article-title":"TSH receptor autoantibodies","volume":"9","author":"Michalek","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2010.05.021_bib11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1210\/jc.2006-2213","article-title":"Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites","volume":"92","author":"Morgenthaler","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.autrev.2010.05.021_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/105072502753522347","article-title":"Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor","volume":"12","author":"Schwarz-Lauer","year":"2002","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.autrev.2010.05.021_bib13","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1210\/en.2004-0789","article-title":"Dissecting linear and conformational epitopes on the native thyrotropin receptor","volume":"145","author":"Ando","year":"2004","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.autrev.2010.05.021_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/thy.2007.0034","article-title":"Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody","volume":"17","author":"Sanders","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-8529(05)70189-4","article-title":"Thyroid autoantibodies","volume":"30","author":"Saravanan","year":"2001","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.autrev.2010.05.021_bib16","first-page":"451","article-title":"Understanding the thyrotropin receptor function\u2013structure relationship","volume":"11","author":"Sanders","year":"1997"},{"key":"10.1016\/j.autrev.2010.05.021_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(74)91815-7","article-title":"Thyroid-stimulating immunoglobulins in Graves' disease","volume":"2","author":"Rees Smith","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2010.05.021_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2265.1982.tb01607.x","article-title":"An improved radioreceptor assay for TSH receptor antibodies","volume":"17","author":"Shewring","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2010.05.021_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2265.1984.tb00102.x","article-title":"A receptor assay for the measurement of TSH receptor antibodies in unextracted serum","volume":"20","author":"Southgate","year":"1984","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.autrev.2010.05.021_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/thy.1999.9.849","article-title":"Comparison of recombinant human thyrotropin receptors versus porcine thyrotropin receptors in the thyrotropin binding inhibition assay for thyrotropin receptor autoantibodies","volume":"9","author":"Kakinuma","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib21","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1210\/jc.84.10.3797","article-title":"The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor","volume":"84","author":"Sanders","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/jc.84.1.90","article-title":"Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease","volume":"84","author":"Costagliola","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib23","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/clinchem\/45.12.2285","article-title":"Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA","volume":"45","author":"Bolton","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2010.05.021_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-8981(00)00385-5","article-title":"Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs","volume":"304","author":"Massart","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2010.05.021_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0038-1632237","article-title":"Clinical implications of a new TSH receptor antibody assay (DYNOtest TRAKhuman) in autoimmune thyroid diseases","volume":"39","author":"Meller","year":"2000","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.autrev.2010.05.021_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1089\/thy.2000.10.1073","article-title":"Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay","volume":"10","author":"Meller","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2265.2001.01347.x","article-title":"TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays","volume":"55","author":"B\u00fclow Pedersen","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.autrev.2010.05.021_bib28","first-page":"115","article-title":"Evaluation of the 2nd generation radio-receptional assay for anti-TSH-receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO)","volume":"45","author":"Giovanella","year":"2001","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.autrev.2010.05.021_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1507\/endocrj.50.113","article-title":"TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor","volume":"50","author":"Kamijo","year":"2003","journal-title":"Endocr J"},{"key":"10.1016\/j.autrev.2010.05.021_bib30","first-page":"111","article-title":"Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation blocking antibodies in Graves' disease","volume":"24","author":"Hirooka","year":"2004","journal-title":"Int J Clin Pharm Res"},{"key":"10.1016\/j.autrev.2010.05.021_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.K05-121","article-title":"TSH receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs","volume":"53","author":"Okamoto","year":"2006","journal-title":"Endocr J"},{"key":"10.1016\/j.autrev.2010.05.021_bib32","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/en.2004-0437","article-title":"Minireview: structural and functional evolution of the thyrotropin receptor","volume":"145","author":"Farid","year":"2004","journal-title":"Endocrinology"},{"issue":"Suppl. 235","key":"10.1016\/j.autrev.2010.05.021_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/003655101753352040","article-title":"Thyroid autoantibodies","volume":"61","author":"Rees Smith","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.autrev.2010.05.021_bib34","first-page":"1","article-title":"Are porcine and human TSH receptor antibody measurements comparable?","volume":"54","author":"Z\u00f6phel","year":"2008","journal-title":"Clin Lab"},{"key":"10.1016\/j.autrev.2010.05.021_bib35","first-page":"243","article-title":"On specificity of 2nd generation TSH receptor autoantibody measurements","volume":"54","author":"Z\u00f6phel","year":"2008","journal-title":"Clin Lab"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2010.05.021_bib36","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1055\/s-2008-1081491","article-title":"Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases","volume":"116","author":"Hermsen","year":"2008","journal-title":"Exp Clin Endocrinol Diab"},{"key":"10.1016\/j.autrev.2010.05.021_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0038-1632256","article-title":"Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease","volume":"39","author":"Z\u00f6phel","year":"2000","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.autrev.2010.05.021_bib38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/105072502321085135","article-title":"Thyroid-stimulating monoclonal antibodies","volume":"12","author":"Sanders","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(03)13866-4","article-title":"Human monoclonal thyroid stimulating autoantibody","volume":"362","author":"Sanders","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2010.05.021_bib40","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/1050725041692918","article-title":"Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function","volume":"14","author":"Sanders","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cca.2009.01.022","article-title":"M22 based (manual) ELISA for TSH-receptor antibody (TRAb) measurement is more sensitive than 2nd generation TRAb assays","volume":"403","author":"Z\u00f6phel","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2010.05.021_bib42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2004.14.830","article-title":"A new assay for thyrotropin receptor autoantibodies","volume":"14","author":"Rees Smith","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/clinchem\/42.1.140","article-title":"Current status and performance goals for serum thyrotropin (TSH) assays","volume":"42","author":"Spencer","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2010.05.021_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0029-1241196","article-title":"TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays","volume":"42","author":"Z\u00f6phel","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2010.05.021_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2008-1077051","article-title":"Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases","volume":"40","author":"Liu","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2010.05.021_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cca.2008.11.025","article-title":"Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies","volume":"401","author":"Hermsen","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2010.05.021_bib47","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2265.2008.03512.x","article-title":"Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease: an international multicentre trial","volume":"71","author":"Schott","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.autrev.2010.05.021_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0029-1246188","article-title":"Reproducibility of Elecsys anti-TSHR test results in a lot-to-lot comparison","volume":"42","author":"Hermsen","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2010.05.021_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1373\/clinchem.2008.115162","article-title":"Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy","volume":"55","author":"Massart","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2010.05.021_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/clinchem\/42.1.160","article-title":"Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor","volume":"42","author":"Feldt-Rasmussen","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2010.05.021_bib51","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF03348001","article-title":"Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects","volume":"20","author":"Takasu","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2010.05.021_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF03348044","article-title":"Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy","volume":"21","author":"Zouvanis","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2010.05.021_bib53","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1210\/jc.74.5.1090","article-title":"Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies","volume":"74","author":"Ilicki","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2265.1995.tb02919.x","article-title":"A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs","volume":"43","author":"Kawai","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2010.05.021_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0038-1625307","article-title":"Deutsche Gesellschaft f\u00fcr Nuklearmedizin. [Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2)]","volume":"42","author":"Dietlein","year":"2003","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.autrev.2010.05.021_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1160\/nukmed-0287","article-title":"Guideline for radioiodine therapy for benign thyroid diseases (version 4)","volume":"46","author":"Dietlein","year":"2007","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.autrev.2010.05.021_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00063-009-1072-0","article-title":"Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology","volume":"104","author":"Eckstein","year":"2009","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.autrev.2010.05.021_bib58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2010.05.021_bib59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/105072502321085225","article-title":"Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine","volume":"12","author":"Hoermann","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib60","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/thy.2005.15.1047","article-title":"Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease","volume":"15","author":"Quadbeck","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2004-814217","article-title":"Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease","volume":"36","author":"Schott","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2010.05.021_bib62","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-2005-921102","article-title":"Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment","volume":"37","author":"Quadbeck","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2010.05.021_bib63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2006.16.295","volume":"16","author":"Carella","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2010.05.021_bib64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1460173","article-title":"Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease","volume":"146","author":"Zimmermann-Belsing","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2010.05.021_bib65","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1210\/jc.83.11.3777","article-title":"Thyroid controversy\u2014stimulating antibodies","volume":"83","author":"Davies","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib66","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib67","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jc.87.2.489","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJM199202203260803","article-title":"Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis","volume":"326","author":"Takasu","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2010.05.021_bib69","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1210\/jcem-71-5-1382","article-title":"Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan","volume":"71","author":"Tamaki","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2010.05.021_bib70","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(00)04060-5","article-title":"Interpretation of thyroid function tests","volume":"357","author":"Dayan","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.autrev.2010.05.021_bib71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.autrev.2009.07.005","article-title":"BLyS and April serum levels in patients with autoimmune thyroid diseases","volume":"9","author":"Fabris","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2010.05.021_bib72","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1126\/science.2556796","article-title":"Molecular cloning of the thyrotropin receptor","volume":"246","author":"Parmentier","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.autrev.2010.05.021_bib73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.83.2.443","article-title":"The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism","volume":"83","author":"Kubota","year":"1998","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T12:07:17Z","timestamp":1591358837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997210001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1568997210001047"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2010.05.021","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}